Molecular Targets and Emerging Therapeutic Options for Uterine Leiomyosarcoma

Uterine leiomyosarcoma (uLMS) is an aggressive malignancy characterized by its early metastasis, high rates of recurrence, and poor prognosis. Multiple obstacles complicate the clinical management of uLMS. These include the fact that most uLMS are typically identified only after a woman has undergon...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, Heather, Ike, Chiemeka, Parma, Jennifer, Masand, Ramya P., Mach, Claire M., Anderson, Matthew L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5046025/
https://www.ncbi.nlm.nih.gov/pubmed/27721667
http://dx.doi.org/10.1155/2016/7018106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5046025/
https://www.ncbi.nlm.nih.gov/pubmed/27721667
http://dx.doi.org/10.1155/2016/7018106

Ejemplares similares